Breaking Finance News

A statement released earlier today by Barclays PLC about Healthways, Inc. (NASDAQ:HWAY) bumps the target price to $27.00

Having a price of $24.90, Healthways, Inc. (NASDAQ:HWAY) traded 1.18% higher on the day. With the last stock price up 76.76% relative to the 200-day moving average, compared with the S&P 500 Index which has decreased -0.01% over the same period. The company has registered a 50-day average of $21.91 and two hundred day moving average of $14.12. Trade volume was was down over the average, with 572,865 shares of HWAY changing hands under the typical 708,248 shares.

Healthways, Inc. (NASDAQ:HWAY) had its estimated target price raised to $27 by Barclays PLC in a report announced Monday August 22 2016. The new target price suggests a potential upside of 0.08% based on the bussiness’ previous closing price.

On 8/12/2016, FBR Capital released a statement for Healthways, Inc.(NASDAQ:HWAY) raised the target price from $21.00 to $28.00. At the time, this indicated a possible upside of 0.24%.

Recent Performance Chart:

Healthways, Inc. (NASDAQ:HWAY)

A total of 6 brokers have reported on HWAY. Two firms rate the stock a strong buy, one analyst rate the stock a buy, four analyts rate the stock a hold, one analyst rate the stock to underperform, and finally 0 analystsrate the company as sell with a one year target stock price of $13.50

Healthways, Inc. has a one-year low of $9.18 and a one-year high of $26.00 and has a market cap of $0.0.

Brief Synopsis On Healthways, Inc. (NASDAQ:HWAY)

Healthways, Inc. (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment. The Company engages entire populations, including health plan memberships, workforces and communities, while in other cases it engages targeted populations, such as members at high-risk, cohorts of cardiac rehabilitation patients or hospital discharge patients. In the United States, it operates in approximately 50 states and the District of Columbia. Its customers include health plans, both commercial and Medicare Advantage, large self-insured employers, including state and municipal government entities, and providers of healthcare, including integrated healthcare systems, and and hospitals.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.